Skip to search formSkip to main contentSkip to account menu

gliquidone

Known as: N-(Cyclohexylcarbamoyl)-4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxo-3,4-dihydroisoquinolin-2(1H)-yl)ethyl]benzenesulfonamide, glikvidon, glycvidon 
A potent, second-generation sulfonylurea with antihyperglycemic activity. Like other second-generation compounds, gliquidone exerts greater binding… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryGliquidone (Glurenorm) and glibenclamide were compared in a cross-over study of 20 non insulin dependent diabetics. Both… 
1999
1999
Six middle-aged (42-59 years old) and six aged (71-75 years old) subjects received each, on separate days, an oral administration… 
1997
1997
The oral hypoglycemic drugs carbutamide, chlorpropamide, glibenclamide, glubornuride, gliclazide, glipizide, gliquidone… 
1990
1990
Abstract— Specific binding of both [3H]glibenclamide and [3H]gliquidone has been observed in a particulate fraction of insulin… 
1984
1984
SummaryThe effects of a sulphonylurea, gliquidone, on insulin binding and the insulin induced rate of glycogen synthesis, were… 
1979
1979
Abstract. Gliquidone (a second generation sulphonylurea) was administered orally to normal rats 1 h before killing. Gliquidone… 
1979
1979
The effect of two second generation sulphonylureas, gliquidone and glibenclamide, on insulin secretion has been studied in the…